Dossier
New therapies
Coverage of New therapies in the Nexus archive.
- Closing the Gap Between Innovation and Access in Myasthenia Gravis Care [Promoted Content]
New therapies are transforming generalized myasthenia gravis care, but unequal access across Europe hinders patient outcomes. Improved diagnosis, specialist referrals, and consistent care access could enhance health system resilience and economic sustainability.
- Gut microbiome can reveal risk of Parkinson’s, scientists say
A study reveals that changes in the gut microbiome can identify individuals at higher risk of Parkinson’s disease years before symptoms appear, with more pronounced alterations in those with genetic risk factors. The findings suggest potential for new therapies targeting the gut microbiome.